ALV 317 (Nevirapine Extended Release 400 mg)
Pill with imprint ALV 317 is White, Capsule-shape and has been identified as Nevirapine Extended Release 400 mg. It is supplied by Alvogen Inc..
Nevirapine is used in the treatment of reduction of perinatal transmission of hiv; hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ALV 317
Nevirapine Extended Release
- Imprint
- ALV 317
- Strength
- 400 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- NNRTIs
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alvogen Inc.
- National Drug Code (NDC)
- 47781-0317
More about nevirapine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 5 Reviews
- Drug class: NNRTIs
Consumer resources
- Nevirapine
- Nevirapine Extended-Release Tablets
- Nevirapine Oral Suspension
- Nevirapine Tablets
- Nevirapine (Advanced Reading)
Other brands: Viramune, Viramune XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
